Anatomy & Physiology Study Guide
4

Membrane Transport, Cell Signaling, and Membrane Potentials

Chapter 4Levels of Organization10 h6 sections, outcomes 1-29Week 2 and Week 3

Slide deck, 30 slidesFlashcards, 89Practice questions, 69 in the bank

4.1

Diffusion, Osmosis, and Tonicity

1 hTuesday, Nov 24, Week 2

Outcomes

  1. 1Apply Fick's law to predict how concentration difference, membrane area, thickness and lipid solubility change the net flux of a solute.
  2. 2Distinguish between osmolarity and tonicity, and classify a solution as isotonic, hypotonic or hypertonic to red blood cells from its composition.
  3. 3Calculate the osmolarity of a given solution and its approximate osmotic pressure using the van't Hoff relationship.
  4. 4Predict the direction and extent of cell volume change when a cell is placed in 0.9% saline, 0.45% saline, 3% saline, 5% dextrose or an isosmotic urea solution.

Outline

  1. A

    Membrane permeability and simple diffusion

    1. Bilayer is permeable to small nonpolar molecules (O2, CO2, N2, steroids, ethanol), poorly to polar molecules (water slowly), and effectively impermeable to ions and large polar solutes.
    2. Permeability tracks the oil/water partition coefficient (Overton's rule) and falls with molecular size; ions cross only via channels or carriers.
    3. Net diffusion comes from random thermal motion; flux is net movement down the electrochemical gradient, never an energy-using process.
    4. Water crosses slowly through the lipid and rapidly through aquaporins (AQP1 red cells and proximal tubule; AQP2 collecting duct, ADH-regulated; AQP4 astrocyte end-feet).
  2. B

    Fick's law and its determinants

    1. J = -D x A x (C1 - C2) / dx, where D is the diffusion coefficient and dx the membrane thickness; lumped as J = P x A x delta-C.
    2. Doubling area (alveolar surface) or halving thickness (thin respiratory membrane) doubles flux; doubling thickness halves it.
    3. Diffusion time scales with the square of distance, so diffusion works over micrometres but fails over centimetres (why capillaries and bulk flow exist).
    4. Charged solutes also feel the electrical gradient: the driving force is the electrochemical gradient (concentration term plus z x F x Vm).
    5. Clinical: pulmonary fibrosis and pulmonary edema thicken the diffusion barrier and lower DLCO.
  3. C

    Osmosis and osmotic pressure

    1. Osmosis is net water movement across a selectively permeable membrane toward the side with higher solute concentration (lower water concentration).
    2. van't Hoff: pi = n x C x R x T; each 1 mOsm/L of osmotic difference generates about 19.3 mm Hg across a membrane that excludes the solute spot-check.
    3. Osmole = one mole of particles, so 1 mmol/L NaCl gives about 2 mOsm/L (ignoring the osmotic coefficient, about 0.93) and glucose gives 1 mOsm/L.
    4. Normal plasma osmolality is about 285-295 mOsm/kg H2O spot-check; ICF and ECF are in osmotic equilibrium, so a change in ECF osmolality moves water into or out of cells within minutes.
    5. Estimate plasma osmolality as 2 x [Na+] + glucose/18 + BUN/2.8 (glucose and BUN in mg/dL).
  4. D

    Osmolarity versus tonicity with worked numbers

    1. Osmolarity counts all dissolved particles; tonicity depends only on effective (membrane-impermeant) solutes and describes the steady-state effect on cell volume.
    2. 0.9% NaCl: 154 mmol/L x 2 = 308 mOsm/L, isosmotic and isotonic (Na+ is effectively excluded by the Na+/K+-ATPase).
    3. 5% dextrose: about 278 mOsm/L, isosmotic on the bag but becomes free water once glucose is metabolized, so it acts hypotonic in vivo.
    4. 300 mOsm/L urea is isosmotic but hypotonic to red cells: urea crosses via UT-B, so water follows and cells swell and lyse.
    5. 0.45% saline is about 154 mOsm/L (hypotonic); 3% saline is about 1026 mOsm/L (hypertonic) and pulls water out of cells.
    6. Clinical: hypotonic fluids in a head-injured patient risk cerebral edema; rapid correction of chronic hyponatremia risks osmotic demyelination.

Lab

  • Worked problems: compute osmolarity and tonicity for 0.9% NaCl, 0.45% NaCl, 3% NaCl, 5% dextrose, 300 mOsm/L urea and lactated Ringer's, then draw the expected steady-state red cell volume for each.
  • Sketch a flux-versus-concentration-difference graph for simple diffusion (straight line) next to carrier-mediated transport (saturating curve) and label the slope with P x A.
  • Calculate plasma osmolality from Na+ 140 mEq/L, glucose 180 mg/dL, BUN 28 mg/dL and state the osmolar contribution of each term.
4.2

Carrier-Mediated and Active Transport

1.5 hTuesday, Nov 24, Week 2

Outcomes

  1. 5Distinguish between simple diffusion, facilitated diffusion, primary active transport and secondary active transport by energy source, direction relative to the gradient and saturability.
  2. 6Explain the saturation kinetics (Vmax, Km) of carrier-mediated transport and why a transport maximum produces glucosuria when plasma glucose is high.
  3. 7Describe the cycle of the Na+/K+-ATPase, its 3 Na+ out : 2 K+ in stoichiometry, its electrogenic contribution and its inhibition by cardiac glycosides.
  4. 8Classify SGLT1, NKCC2, NCX, NHE, GLUT4, SERCA, H+/K+-ATPase and CFTR as uniport, symport, antiport, ATPase or channel and name the driving force for each.

Outline

  1. A

    Facilitated diffusion and carrier kinetics

    1. Carriers bind solute on one face, change conformation and release it on the other; rate is limited by the number of carriers and turnover, so flux saturates at Vmax.
    2. Km is the concentration giving half-maximal transport and reflects carrier affinity; competing substrates raise the apparent Km.
    3. GLUT family are uniporters: GLUT1 (RBC, brain barrier), GLUT2 (liver, beta cell, basolateral tubule and enterocyte), GLUT4 (insulin-dependent muscle and fat), GLUT5 (fructose).
    4. Insulin recruits GLUT4 vesicles to the surface (see 4.4 and 4.3); defective recruitment is part of insulin resistance.
    5. Clinical: renal glucose Tm is about 375 mg/min and the plasma threshold about 180-200 mg/dL, above which glucosuria appears (diabetes mellitus) spot-check.
  2. B

    Primary active transport

    1. An ATPase couples ATP hydrolysis directly to uphill movement; classes: P-type (Na+/K+, Ca2+, H+/K+), V-type (lysosome, osteoclast H+), ABC transporters (CFTR, MDR1).
    2. Na+/K+-ATPase cycle: 3 Na+ bind from the cytosol, phosphorylation of the alpha subunit, conformational change, 3 Na+ released outside, 2 K+ bind, dephosphorylation, 2 K+ released inside.
    3. Net one positive charge out per cycle (electrogenic), adding roughly -4 mV directly to the resting potential; the major effect is maintaining gradients spot-check.
    4. Pump uses a large share of cellular ATP (roughly 20-40% in many tissues, up to about two thirds in neurons) spot-check.
    5. Ouabain and digoxin inhibit the K+ site; less pumping raises intracellular Na+, which reduces Ca2+ extrusion by NCX and increases cardiac contractility.
    6. Other pumps: SERCA and PMCA keep cytosolic Ca2+ near 100 nM versus about 1-2 mM outside spot-check; gastric H+/K+-ATPase is blocked by proton pump inhibitors.
  3. C

    Secondary active transport

    1. Uses the Na+ electrochemical gradient built by the Na+/K+-ATPase; Na+ moves in and drags a second solute against its gradient (symport) or pushes one out (antiport).
    2. Symport examples: SGLT1 (2 Na+ : 1 glucose or galactose, gut and proximal tubule), SGLT2 (1 Na+ : 1 glucose, early proximal tubule), NKCC2 (1 Na+, 1 K+, 2 Cl-, thick ascending limb), Na+-amino acid carriers.
    3. Antiport examples: NCX (3 Na+ in : 1 Ca2+ out), NHE (Na+ in, H+ out), Cl-/HCO3- exchanger AE1.
    4. Drug links: loop diuretics block NKCC2; SGLT2 inhibitors (empagliflozin) lower plasma glucose via glycosuria.
    5. Energy: Na+ gradient is 'stored' ATP energy; cardiac cell inhibition of the pump indirectly weakens NCX and SGLT function.
  4. D

    Comparing transport modes

    1. Simple diffusion: no carrier, no saturation, down gradient, no energy.
    2. Facilitated diffusion: carrier, saturable, down gradient, no energy, stereospecific and inhibitable.
    3. Primary active: ATP, saturable, can move against gradient, inhibitable by poisons that deplete ATP.
    4. Secondary active: needs an ion gradient not ATP directly; collapse of the Na+ gradient stops it.

Lab

  • Plot Vmax and Km on a Michaelis-Menten curve for a carrier, then redraw it with a competitive inhibitor and with half the carrier number.
  • Diagram a polarized epithelial cell and place Na+/K+-ATPase, NKCC2, SGLT1, GLUT2 and NHE on correct membranes with arrows for each ion.
  • Draw the Na+/K+-ATPase cycle as a five-step circular scheme labelling E1, E2, phosphorylated states and ion counts.
4.3

Vesicular and Transepithelial Transport

1 hWednesday, Nov 25, Week 2

Outcomes

  1. 9Compare phagocytosis, pinocytosis, clathrin-mediated receptor-mediated endocytosis and caveolae-mediated uptake, giving one physiological example of each.
  2. 10Describe the steps of regulated exocytosis, including the roles of Ca2+, SNARE proteins and synaptotagmin.
  3. 11Trace a glucose molecule from intestinal lumen to blood by transepithelial transport, naming each apical and basolateral transporter.
  4. 12Distinguish between transcellular and paracellular pathways, and relate tight junction permeability to leaky and tight epithelia.

Outline

  1. A

    Endocytosis

    1. Phagocytosis: actin-driven engulfment of large particles (more than 0.5 micrometres) by macrophages and neutrophils; the phagosome fuses with lysosomes.
    2. Pinocytosis: constitutive uptake of fluid and solutes in small vesicles of about 100-200 nm.
    3. Receptor-mediated: ligand binds receptor in clathrin-coated pits; adaptor proteins AP2, dynamin pinches off; the vesicle uncoats and delivers to early endosome for sorting.
    4. Examples: LDL receptor, transferrin iron uptake, and insulin receptor internalization; receptor often recycles to the surface.
    5. Clinical: LDL receptor defects cause familial hypercholesterolemia; viruses and toxins hijack clathrin pathways.
  2. B

    Exocytosis and membrane trafficking

    1. Constitutive exocytosis delivers membrane proteins and secreted proteins continuously; regulated exocytosis stores vesicles until a Ca2+ signal.
    2. v-SNAREs (synaptobrevin) on vesicle pair with t-SNAREs (syntaxin, SNAP-25) on the target membrane; synaptotagmin senses Ca2+ and triggers fusion.
    3. Fusion adds membrane area, which is later retrieved by endocytosis to keep surface area constant.
    4. Clinical: botulinum and tetanus toxins cleave SNARE proteins and block neurotransmitter release.
    5. Insulin-triggered GLUT4 exocytosis in muscle and fat is a physiological example of regulated membrane insertion.
  3. C

    Transcytosis

    1. Vesicle takes cargo across a cell from one surface to the other (maternal IgG across the placenta by FcRn, IgA via pIgR into secretions).
    2. Capillary endothelium moves some protein and fluid through caveolae-derived vesicles.
    3. Cargo can bypass lysosomal degradation when sorted from the early endosome to the opposite membrane.
  4. D

    Transepithelial transport

    1. Polarized epithelia keep different transporters in apical and basolateral membranes; tight junctions prevent mixing of the two membrane domains.
    2. Intestinal glucose absorption: SGLT1 (apical, 2 Na+ : 1 glucose) -> glucose exits through GLUT2 (basolateral); basolateral Na+/K+-ATPase keeps cellular Na+ low and drives the process.
    3. Water follows solute through aquaporins and the paracellular route; oral rehydration solutions rely on Na+-glucose symport.
    4. Secretion works in reverse: CFTR (apical Cl- channel) plus basolateral NKCC1 drives Cl- and water secretion; cholera toxin and CFTR mutations alter this.
  5. E

    Paracellular pathway

    1. Tight junction claudins set size and charge selectivity: leaky epithelia (proximal tubule, gallbladder) via claudin-2; tight epithelia (collecting duct, bladder) restrict ions.
    2. Transepithelial resistance varies from about 5 ohm-cm2 to more than 1000 ohm-cm2 spot-check.
    3. Paracellular Mg2+ and Ca2+ reabsorption in the thick ascending limb depends on claudin-16/19; mutations cause hypomagnesemia.

Lab

  • Histology Guide MH-119 ileum: identify the striated (brush) border and describe which transporters sit on it versus the basolateral membrane.
  • Draw a labelled enterocyte showing SGLT1, GLUT2, GLUT5, Na+/K+-ATPase, tight junction and the paracellular route.
  • Make a flow chart of the clathrin-coated pit to early endosome to lysosome or recycling pathway for an LDL particle.
4.4

Cell Signaling: Receptors and Second Messengers

2 hFriday, Nov 27, Week 2

Outcomes

  1. 13Classify cell-surface and intracellular receptors (ligand-gated channels, GPCRs, receptor tyrosine kinases, cytokine receptors, guanylyl cyclase receptors, nuclear receptors) and give a ligand for each.
  2. 14Trace the Gs-adenylyl cyclase-cAMP-PKA and the Gq-PLC-IP3/DAG-Ca2+-PKC pathways from ligand binding to cellular response.
  3. 15Explain how receptor tyrosine kinases such as the insulin receptor activate the PI3K-Akt and Ras-MAPK pathways.
  4. 16Describe how lipophilic hormones act through nuclear receptors to change gene transcription, and why their effects are slower and longer lived.
  5. 17Predict the effect of cholera toxin, pertussis toxin, phosphodiesterase inhibitors and receptor blockers on a given second messenger pathway.

Outline

  1. A

    Principles of signaling

    1. Ligand (first messenger) binds with specificity and affinity to a receptor; response is saturable, with dose-response curve characterized by EC50.
    2. Signal types: endocrine, paracrine, autocrine, juxtacrine, synaptic; hydrophilic ligands need cell-surface receptors, lipophilic ligands (steroids, thyroid hormone) cross the membrane.
    3. Amplification: one receptor activates many G proteins, one adenylyl cyclase makes many cAMP; signal is terminated by GTP hydrolysis, phosphodiesterases and phosphatases.
    4. Desensitization: GRK phosphorylation and beta-arrestin binding uncouple and internalize receptors; chronic agonist exposure downregulates receptor number.
  2. B

    Ligand-gated ion channels

    1. Fastest (milliseconds); ligand opens a pore: nicotinic ACh receptor (Na+/K+ cation channel), GABA-A and glycine (Cl-), NMDA/AMPA (cation).
    2. Produce graded postsynaptic potentials (EPSP, IPSP); this is the basis of neuromuscular and fast synaptic transmission (later chapters).
  3. C

    G protein-coupled receptors and second messengers

    1. Seven-transmembrane receptor; agonist binding makes the receptor exchange GDP for GTP on the heterotrimeric G protein alpha subunit, which dissociates from beta-gamma.
    2. Gs stimulates adenylyl cyclase: ATP -> cAMP -> PKA -> phosphorylation of targets (beta1 receptor in heart raises contractility, glucagon receptor promotes glycogenolysis).
    3. Gi inhibits adenylyl cyclase (M2 muscarinic, alpha2, D2); Gi beta-gamma also opens GIRK K+ channels in the sinoatrial node.
    4. Gq activates PLC-beta: PIP2 -> IP3 + DAG; IP3 opens ER IP3 receptors releasing Ca2+, DAG with Ca2+ activates PKC (alpha1 vascular tone, M3, angiotensin AT1).
    5. Ca2+ acts via calmodulin and CaMK; cAMP is degraded by phosphodiesterase (caffeine and theophylline inhibit it).
    6. Toxins: cholera toxin locks Gs on (secretory diarrhea); pertussis toxin ADP-ribosylates Gi (loss of inhibition).
  4. D

    Enzyme-linked receptors

    1. Receptor tyrosine kinases (insulin, IGF-1, EGF, PDGF, VEGF) dimerize on ligand binding and trans-autophosphorylate tyrosines, creating docking sites for adaptor proteins.
    2. Insulin receptor phosphorylates IRS proteins -> PI3K -> PIP3 -> Akt, producing GLUT4 translocation and glycogen synthesis; Ras -> Raf -> MEK -> ERK drives growth.
    3. Cytokine receptors (EPO, growth hormone, interferons) have no intrinsic kinase and recruit JAK, which phosphorylates STAT; STAT dimers enter the nucleus.
    4. Guanylyl cyclase receptors (ANP, BNP) and soluble guanylyl cyclase (nitric oxide) make cGMP -> PKG -> smooth muscle relaxation; sildenafil blocks PDE5.
    5. Clinical: imatinib targets BCR-ABL tyrosine kinase; EGFR and HER2 inhibitors treat cancers; BRAF mutations (V600E) constitutively activate MAPK.
  5. E

    Nuclear receptors

    1. Cortisol, aldosterone, sex steroids, thyroid hormone, vitamin D and retinoic acid bind receptors in cytoplasm or nucleus; the hormone-receptor complex binds hormone response elements.
    2. Effects need minutes to hours (transcription and translation) and last longer; hormones are carried by binding proteins in plasma.
    3. Clinical: tamoxifen antagonizes the estrogen receptor; thyroid hormone resistance results from receptor mutations.

Lab

  • Draw the Gs/cAMP and Gq/IP3-DAG pathways side by side on one page and mark where cholera toxin, caffeine and a beta-blocker act.
  • Diagram insulin receptor signaling from ligand binding to GLUT4 insertion and to MAPK-mediated growth.
  • Fill a table of 10 receptors by class, G protein, second messenger and tissue response (beta1, beta2, alpha1, alpha2, M2, M3, V2, AT1, glucagon, ANP).
4.5

Resting Membrane Potential

2 hMonday, Nov 30, Week 3

Outcomes

  1. 18Explain how the K+ concentration gradient and K+ leak channels generate the resting membrane potential.
  2. 19Calculate the equilibrium potential of K+, Na+, Cl- and Ca2+ with the Nernst equation from typical intracellular and extracellular concentrations.
  3. 20Use the Goldman-Hodgkin-Katz equation to predict how changing relative ion permeabilities or extracellular K+ moves the membrane potential.
  4. 21Describe the contribution of the Na+/K+-ATPase to the resting potential and distinguish its direct electrogenic from its indirect gradient-maintaining roles.
  5. 22Predict the effects of hypokalemia and hyperkalemia on resting membrane potential and excitability.

Outline

  1. A

    Ionic distribution and basic electrophysiology

    1. Typical mammalian concentrations (mEq/L, ECF / ICF): Na+ 142 / 14; K+ 4 / 140; Cl- 103 / 4; HCO3- 28 / 10; Ca2+ about 2.4 total (1.2 free) / about 0.0001 free spot-check.
    2. Cell interior is rich in impermeant anions (proteins, organic phosphates), so the Gibbs-Donnan distribution contributes to K+ accumulation.
    3. Ohm's law for ions: I = g x (Vm - Eion); driving force is the difference between Vm and the ion's equilibrium potential.
    4. Membrane behaves like a capacitor (about 1 microF/cm2) in parallel with ion conductances; charge separation of only a few ions per million is needed.
  2. B

    Nernst equation

    1. E = (RT/zF) ln(Co/Ci); at 37 degrees C and with log10 this is 61 mV x log(Co/Ci)/z, i.e. E_K = -61 log(140/4) = about -94 mV.
    2. E_Na = +61 log(142/14) = about +61 mV; E_Ca about +120 to +130 mV; E_Cl about -70 to -90 mV depending on the cell spot-check.
    3. A tenfold concentration ratio of a monovalent ion equals about 61 mV (about 58 mV at room temperature).
    4. At equilibrium potential net flux of that ion is zero because the electrical and concentration forces balance.
  3. C

    Goldman-Hodgkin-Katz equation and relative permeability

    1. Vm = 61 log[(P_K Ko + P_Na Nao + P_Cl Cli)/(P_K Ki + P_Na Nai + P_Cl Clo)]; weighted by permeabilities, so the most permeant ion dominates.
    2. At rest P_K far exceeds P_Na (about 50-100 : 1), giving Vm of about -70 to -90 mV in neurons and about -90 mV in skeletal and ventricular muscle.
    3. In large nerve fibers Guyton reports -90 mV: K+ diffusion alone gives about -94 mV, Na+ leak adds about +3 mV and the pump about -4 mV spot-check.
    4. Vm moves toward the Nernst potential of whichever ion's permeability increases (K+ opening hyperpolarizes; Na+ opening depolarizes).
  4. D

    Role of the Na+/K+-ATPase

    1. Directly electrogenic (3 out : 2 in) adding a few millivolts of hyperpolarization; its major role is maintaining the Na+ and K+ gradients over minutes to hours.
    2. Brief pump inhibition does not abolish Vm at once because ion reserves are large; sustained ATP loss collapses the gradients (ischemia, depolarization).
    3. Glial cells and the pump clear extracellular K+ after neural activity.
  5. E

    Extracellular K+ and clinical correlation

    1. Raising Ko from 4 to 8 mM shifts E_K from about -94 to -76 mV: -61 log(140/8) = -76 mV; lowering to 2 mM gives about -112 mV.
    2. Hyperkalemia depolarizes cells, initially increasing excitability; sustained depolarization inactivates Na+ channels, causing weakness, peaked T waves and conduction block (ECG changes).
    3. Hypokalemia hyperpolarizes cells, causing weakness and ileus; ECG shows U waves and ST depression; digitalis toxicity worsens with hypokalemia.
    4. Succinylcholine and tissue injury release K+; insulin and beta2 agonists drive K+ into cells via the Na+/K+-ATPase.

Lab

  • Calculate E_K, E_Na, E_Cl and E_Ca from the concentration table above, then draw them on a single voltage axis from -100 to +130 mV.
  • Use the GHK equation with P_K : P_Na : P_Cl = 1 : 0.04 : 0.45 and the table values to compute Vm, then recompute with P_Na tenfold higher.
  • Plot Vm versus log Ko (2, 4, 6, 8, 10 mM) and mark where hyperkalemia ECG changes begin.
4.6

Action Potentials and Their Propagation

2.5 hTuesday, Dec 1, Week 3

Outcomes

  1. 23Describe the phases of a neuronal action potential and name the ion movement and channel states responsible for each phase.
  2. 24Explain the roles of the m (activation) and h (inactivation) gates of the voltage-gated Na+ channel and of delayed-rectifier K+ channels in firing and repolarization.
  3. 25Distinguish between graded potentials and action potentials, and explain threshold, the all-or-none principle and temporal and spatial summation.
  4. 26Compare absolute and relative refractory periods, and explain how they determine firing frequency and one-way propagation.
  5. 27Describe continuous and saltatory conduction, and predict how axon diameter, myelination and the length constant change conduction velocity.
  6. 28Explain how local anesthetics, tetrodotoxin, hyperkalemia and hypocalcemia alter excitability.
  7. 29Relate demyelinating diseases to slowed or blocked conduction.

Outline

  1. A

    Phases of the action potential

    1. Resting at about -70 to -90 mV; a stimulus depolarizes to threshold (about -55 to -65 mV); rapid Na+ influx gives upstroke to about +30 to +35 mV.
    2. Peak is limited by Na+ channel inactivation and by approach to E_Na (+61 mV); repolarization follows by Na+ inactivation plus delayed K+ efflux.
    3. Afterhyperpolarization occurs while K+ channels remain open, driving Vm toward E_K (-94 mV) before channels close.
    4. Whole action potential lasts about 1-2 ms in nerve and skeletal muscle; ionic changes per spike are tiny (well below 1% of concentrations) and are reset by the Na+/K+-ATPase.
  2. B

    Voltage-gated channels

    1. Na+ channel: activation gate (m) opens quickly on depolarization; inactivation gate (h) closes more slowly and stays closed until repolarization removes it.
    2. Positive feedback: depolarization opens Na+ channels, causing more depolarization (regenerative); about 10 mV above threshold means inward current exceeds outward K+ current.
    3. K+ channel (delayed rectifier) opens slowly, so repolarization occurs just as Na+ channels inactivate; it adds to the afterhyperpolarization.
    4. Ca2+ channels contribute plateau phases (cardiac ventricular, smooth muscle) and are discussed in the heart and muscle chapters.
    5. Channels have states (closed, open, inactivated); the same channel protein cycles through them in sequence, not by chance.
  3. C

    Graded potentials, threshold and summation

    1. Graded potentials (receptor, postsynaptic, end-plate) are decremental, vary in amplitude with stimulus size and can be summated; action potentials are all-or-none and non-decremental.
    2. Threshold is the Vm at which inward Na+ current first exceeds outward K+ current; the axon hillock or initial segment has the lowest threshold because of high Na+ channel density.
    3. Temporal summation (rapid successive inputs) and spatial summation (several inputs together) can bring a neuron to threshold; EPSPs depolarize and IPSPs hyperpolarize.
    4. Stimulus intensity is encoded by firing frequency and number of fibers recruited, not by spike size.
  4. D

    Refractory periods and excitability

    1. Absolute refractory period (about 1 ms): no stimulus fires another spike because Na+ channels are inactivated; sets maximum firing rate near 1000/s theoretically.
    2. Relative refractory period: stronger-than-normal stimulus needed while some channels have recovered and K+ efflux persists.
    3. Refractoriness ensures unidirectional propagation and prevents summation or tetanus of the AP itself (cardiac AP refractoriness is far longer; see heart chapters).
    4. Hyperkalemia depolarizes and inactivates Na+ channels; hypocalcemia lowers threshold (surface charge effect), causing tetany and Chvostek or Trousseau signs.
    5. Local anesthetics (lidocaine) block the Na+ channel more in rapidly firing cells (use dependence); tetrodotoxin blocks it from the outside; carbamazepine and phenytoin act similarly.
  5. E

    Propagation and conduction velocity

    1. Local circuit currents depolarize the next segment to threshold; the segment behind is refractory, so the spike moves one way.
    2. Conduction velocity rises with axon diameter (lower axial resistance) and with myelination; ranges from about 0.25 m/s (unmyelinated C fibers) to about 100 m/s (large myelinated fibers) spot-check.
    3. Length constant lambda = sqrt(r_m / r_i): larger diameter and higher membrane resistance (myelin) increase lambda, so depolarization spreads farther.
    4. Myelin increases membrane resistance and decreases capacitance, so current jumps node to node (saltatory conduction); nodes of Ranvier (about 1 micrometre) carry dense Na+ channels.
    5. Saltatory conduction raises speed about 50-fold and saves energy because only nodes depolarize, so the pump works less.
  6. F

    Fiber types and disorders of conduction

    1. Fiber classes: A-alpha (proprioception, motor, 70-120 m/s), A-beta (touch), A-delta (fast pain, cold, thin myelin about 5-30 m/s), C (slow pain, unmyelinated, 0.5-2 m/s) spot-check.
    2. Local anesthetics block small fibers first (pain, then touch, then motor); pressure and ischemia block large fibers first.
    3. Demyelination (multiple sclerosis in CNS, Guillain-Barre in PNS) increases capacitance and decreases lambda, slowing or blocking conduction; temperature rises worsen it (Uhthoff phenomenon).
    4. Channelopathies: SCN gene mutations cause epilepsy and periodic paralysis; Lambert-Eaton and neuromyotonia alter channel function.

Lab

  • Draw and label an action potential on a Vm-versus-time axis with threshold, overshoot, repolarization and afterhyperpolarization, and overlay g_Na and g_K traces.
  • Draw a Na+ channel in resting, open and inactivated states, marking the m and h gates and the Vm at which each state occurs.
  • Compute relative conduction times over 1 m for a 0.5 m/s C fiber, a 15 m/s A-delta fiber and a 100 m/s A-alpha fiber.
  • Interpret an extracellular stimulus-response plot showing absolute and relative refractory periods and a strength-duration curve (rheobase, chronaxie).

Teach-back prompts

  1. Using the Nernst and Goldman equations, explain why a neuron rests near -70 to -90 mV and how that value changes when extracellular K+ rises from 4 to 8 mM.
  2. Walk through an action potential from threshold to recovery, naming each channel state and the ion flux, then explain why it travels in only one direction.
  3. Trace a glucose molecule and its associated Na+ from the intestinal lumen to blood, identifying which steps are passive, primary active and secondary active.
  4. Explain how a hormone acting through a Gs-coupled receptor and one acting through a nuclear receptor produce different time courses and what you would expect if cholera toxin were present.

Practical targets

  • Plot of Nernst potentials on a -100 to +130 mV axis
  • Action potential diagram with threshold, overshoot and afterhyperpolarization
  • Na+ channel state diagram (closed, open, inactivated)
  • Na+/K+-ATPase cycle diagram
  • Enterocyte transport diagram (SGLT1, GLUT2, Na+/K+-ATPase)
  • Gs/cAMP and Gq/IP3-DAG pathway diagrams
  • Insulin receptor signaling diagram
  • Red cell shape in hypotonic, isotonic and hypertonic solutions
  • Histology Guide MH-119 ileum brush border
  • Michaelis-Menten curve for carrier-mediated transport
  • Refractory period / strength-duration curve
  • Saltatory conduction at nodes of Ranvier

Also see